Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus Mitsuro KandaMasahiko KoikeYasuhiro Kodera Thoracic Oncology 24 October 2019 Pages: 1233 - 1240
Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus Flávio Roberto TakedaFrancisco TustumiIvan Cecconello Thoracic Oncology 29 October 2019 Pages: 1241 - 1247
ASO Author Reflections: Evaluation of Tumor Regression After Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma—How to Do It? Flavio Roberto TakedaFrancisco TustumiIvan Cecconello ASO Author Reflections 31 October 2019 Pages: 1248 - 1249
External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer Sebastian BrinkmannBo J. NoordmanUta Drebber Thoracic Oncology Open access 05 November 2019 Pages: 1250 - 1258
Impact on Health-Related Quality of Life of Video-Assisted Thoracoscopic Surgery for Lung Cancer Kerry N. L. AveryJane M. BlazebyDoug West Thoracic Oncology Open access 01 December 2019 Pages: 1259 - 1271
Perioperative Detection of Circulating Tumor Cells in Radical or Partial Nephrectomy for Renal Cell Carcinoma Nobuhiro HagaAkifumi OnagiYoshiyuki Kojima Urologic Oncology 12 December 2019 Pages: 1272 - 1281
ASO Author Reflections: Increase of Circulating Tumor Cells After Open Radical Nephrectomy Compared with Other Surgical Modalities Nobuhiro Haga ASO Author Reflections 13 January 2020 Pages: 1282 - 1283
A Novel Prediction Tool Based on Multiparametric Magnetic Resonance Imaging to Determine the Biopsy Strategy for Clinically Significant Prostate Cancer in Patients with PSA Levels Less than 50 ng/ml Bi-Ming HeZhen-Kai ShiHai-Feng Wang Urologic Oncology 17 December 2019 Pages: 1284 - 1295
ASO Author Reflections: A Pair of Nomograms to Choose Appropriate Prostate Biopsy Strategy Bi-Ming HeYing-Hao SunHai-Feng Wang ASO Author Reflections 16 January 2020 Pages: 1296 - 1296
Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis Lingxiao ChenZhenyu OuLong Wang Urologic Oncology 18 December 2019 Pages: 1297 - 1303
ASO Author Reflections: Evaluation of Neoadjuvant Chemotherapy in the Treatment of High-Grade Upper Tract Urothelial Carcinoma Long Wang ASO Author Reflections 10 January 2020 Pages: 1304 - 1305
Commentary and Complementary Data to Add to “Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer’s Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections” Mary CharltonAmanda KahlIngrid Lizarraga Colorectal Cancer 02 January 2020 Pages: 1306 - 1307
Dr Charlton et al., Commentary and Complementary Data to Add to “Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer’s Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections” Lawrence N. Shulman Health Services Research and Global Oncology 19 December 2019 Pages: 1308 - 1308